Evidence map›Paper›PMID 30498693›Full record

ArticleFrontiers in oncology2018

Simultaneous

Morteza Esmaeili, Nassim Tayari, Tom Scheenen, Mattijs Elschot, Elise Sandsmark, Helena Bertilsson, Arend Heerschap, Kirsten M Selnæs, Tone F Bathen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Morteza EsmaeiliDeparment of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Nassim TayariDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Tom ScheenenDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Mattijs ElschotDeparment of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Elise SandsmarkDeparment of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Helena BertilssonDepartment of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Arend HeerschapDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Kirsten M SelnæsDeparment of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Tone F BathenDeparment of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

benign prostatic hyperplasiachemical shift imagingcitratemagnetic resonance spectroscopypositron emission tomographyprostate cancer

Identifiers

PMID30498693
PMCPMC6249271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.